Previous close | 10,914.00 |
Open | 10,914.00 |
Bid | 10,822.00 x 0 |
Ask | 10,826.00 x 0 |
Day's range | 10,764.00 - 10,934.00 |
52-week range | 9,461.00 - 12,348.00 |
Volume | |
Avg. volume | 2,904,161 |
Market cap | 167.766B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 35.37 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (2.09%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
Facing accusations of greed, the pay packages of FTSE CEOs are back in the headlines. But our writer takes a more relaxed view, on one condition. The post I don’t care how much FTSE bosses are paid as long as they make me rich! appeared first on The Motley Fool UK.
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.